Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Rough market day for Nektar, while Pharmacyclics and Regeneron soar
Marketwatch
Fri, 09/27/13 - 08:37 am
Tags:
Nektar, Pharmacyclics, Regeneron, osteoarthritis, NKTR-181, ibrutinib
Sanofi cholesterol drug touted as potential $3 billion blockbuster
Reuters
Thu, 09/26/13 - 10:25 am
Tags:
Sanofi, Regeneron, alirocumab, PCSK9 inhibitors
Who are the richest biopharma execs? Not all the usual suspects
Fierce Pharma
Tue, 09/24/13 - 11:12 am
Tags:
executive pay, Regeneron
Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas
Yahoo/Wall St 24-7
Mon, 09/16/13 - 10:09 am
Tags:
biotech, Th2 immune pathway, MS, multiple sclerosis, Biogen Idec, Regeneron, Sanofi, GSK
Regeneron Pharma Soars As Sanofi Mulls Doubling Stake
investors.com
Sat, 09/14/13 - 10:39 am
Tags:
Regeneron, Sanofi
Biogen Tops 4 Big Biotechs For A Healthy Portfolio
Investors.com
Wed, 09/11/13 - 08:52 am
Tags:
Biogen Idec, Celgene, Alexion, Regeneron
Novartis announces global licensing, research collaboration with Regenerex
Yahoo/Fly on the Wall
Fri, 09/6/13 - 08:21 am
Tags:
Novartis, Regeneron, R&D, liscensing
Are Biotech M&A Premiums Already Built In? Valuations Do Matter
Seeking Alpha
Tue, 09/3/13 - 04:19 pm
Tags:
biotech, M&A, ONYX Pharmaceuticals, Alexion, Biomarin, Incyte, Medivation, Pharmacyclics, Regeneron, Seattle Genetics
Regeneron's CEO Talks About His Drugs For Eye Disease, Cholesterol, And Asthma Comment Now Follow Comments
Forbes
Thu, 08/15/13 - 11:57 am
Tags:
Regeneron, Pharma CEOs, Eylea, Leonard Schleifer, PCSK9 inhibitors
Between RX and A Hard Place: Biotechs Flash Warnings
Investors.com
Tue, 08/13/13 - 11:00 am
Tags:
Alexion, BiogenIdec, Santarus, Regeneron
How Much To Develop A Drug? An Update
Seeking Alpha
Mon, 08/12/13 - 11:51 am
Tags:
R&D, AstraZeneca, Bayer, Eli Lilly, Novartis, Pfizer, Regeneron, Roche, Shire, Takeda
Regeneron: Q2 Results And Eylea Data Support The Long-Term Thesis
Seeking Alpha
Sat, 08/10/13 - 12:37 pm
Tags:
Regeneron, earnings
Regeneron: Q2 Results And Eylea Data Support The Long-Term Thesis
Seeking Alpha
Fri, 08/9/13 - 04:57 pm
Tags:
earnings, Regeneron, Eylea, Amgen, Novartis, Pfizer, Sanofi
Should You Keep an Eye on These Eye Treatment Biotechs?
Motley Fool
Fri, 08/9/13 - 10:30 am
Tags:
wet age-related macular degeneration, diabetic macular edema, Lucentis, Novartis, Roche, Eylea, Regeneron, Optina, Ampio Pharmaceuticals
Is There Pipeline Potential in These 3 Biotech Stocks?
Motley Fool
Thu, 08/8/13 - 09:02 am
Tags:
Regeneron, REGN-727, dupilumab, Abexinostat, Pharmacyclics, AVI-7288, Sarepta Therapeutics
Regeneron Posts Rare Sales Miss But Counters With Early FDA Filing
TheStreet.com
Tue, 08/6/13 - 11:00 am
Tags:
Regeneron, FDA, earnings, Eylea, DME
Ampio's Eye Drug Approval Strategy Dealt Another Credibility Hit
TheStreet.com
Tue, 08/6/13 - 10:54 am
Tags:
Ampio Pharmaceuticals, Regeneron, Eylea, Optina, DME
6 Oncology-Focused Biotech Growth Engines
Seeking Alpha
Sat, 08/3/13 - 10:33 am
Tags:
Celgene, Regeneron, Biogen Idec, Gilead Sciences, ONYX Pharmaceuticals, Celldex
Regeneron Pharmaceuticals Inc (REGN) Earnings Expected to Rise
Forbes
Sat, 08/3/13 - 10:14 am
Tags:
Regeneron, earnings
Regeneron Pharmaceuticals Inc (REGN) Earnings Expected to Rise
Forbes
Fri, 08/2/13 - 01:15 pm
Tags:
earnings, Regeneron

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.